Polymerization of PEG in blood plasma by coagulation factor XIIIa exhibits a spatially-propagating front and increases the adhesion of clots

Abstract

Event Abstract Back to Event Polymerization of PEG in blood plasma by coagulation factor XIIIa exhibits a spatially-propagating front and increases the adhesion of clots Karen Y. Chan1, Ju Hun Yeon1, Ting-Chia Wong1, Chunyi Zhao1 and Christian J. Kastrup1 1 University of British Columbia, Michael Smith Laboratories, Canada Introduction: Despite an increasing number of hemostatic agents available[1], bleeding still accounts for roughly half of all trauma deaths in hospitals[2]. The natural coagulation system is usually effective at halting moderate bleeding, and thus creating new materials that mimic fibrin may lead to new hemostatic agents[3]. Unique properties of fibrin include its ability to polymerize as a propagating reactive front[3], and its strong adhesion to injured tissues[4], which is catalyzed by the transglutaminase coagulation factor XIIIa (FXIIIa)[5]. We hypothesized that adding a FXIIIa-crosslinkable material to clots would make them more adhesive. Here, we show that a well-characterized FXIIIa-crosslinkable material[6]-[9] can mimic fibrin to polymerize by spatial propagation and increase clot adhesion. Materials and Methods: A glutamine-donating peptide substrate of FXIIIa was conjugated to PEG (Gln-PEG) and formulated with an amine-donor, spermidine, in plasma as described[10]. To measure frontal propagation, this mixture was flowed into tissue factor(TF)-patterned microfluidic channels[11] and polymerization was traced by time-lapse microscopy. To measure adhesion, a mix containing normal plasma (36%v/v), Gln-PEG (44mg/mL), spermidine (1.2mM), CaCl2 (4.8mM), NaCl (11mM), purified FXIII (0.18mg/mL), and APTT activator (2.4% v/v) was clotted between glass substrates. A lap-shear test was done using a mechanical analyzer (TA Q800). Results and Discussion: The self-assembly and polymerization of fibrin during clotting is a rare example of frontal polymerization in nature, where gelation spatially propagates as a reactive front[3]. To test whether a FXIIIa-crosslinkable synthetic material could mimic frontal polymerization of fibrin clots without flow, Gln-PEG and spermidine were added to fibrinogen(Fg)-deficient plasma in a microfluidic channel patterned with clot activator, TF (Fig.1A-E). Polymerization initiated at TF then propagated through stagnant plasma (32m/min, Fig.1F) similar to Fg-rich clots (21 m/min, Fig.1G). In contrast, when preactivated FXIIIa was added to Gln-PEG-spermidine, polymerization was uniform and did not propagate (Fig.1H). This shows that frontal polymerization in coagulation is dependent on the coagulation cascade, and a FXIIIa-crosslinkable synthetic material can mimic this unique polymerization property of fibrin. To test if adding a FXIIIa-crosslinkable material makes clots more adhesive, Gln-PEG and spermidine were added to plasma and the composite clot’s adhesion was measured in a lap-shear test (Fig.2A). Shear strength increased from 1.3kPa to 5.6kPa (Fig.2B). This shows a FXIIIa-crosslinkable synthetic material can supplement Fg to increase clot adhesion. Conclusion: Coupling the polymerization of a synthetic material to the coagulation cascade allows it to mimic fibrin’s ability to form and adhere in response to signals of vascular injury. This strategy may be useful for developing novel hemostatic materials. This work was funded by the Canadian Institutes of Health Research (MOP-119426 and MSH-130166), the Canadian Foundation for Innovation (31928), and the BC Knowledge Development Fund.